Weihua Cao
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial”.
Martti Antila, Joachim H. Ficker, И. Г. Гордеев, Alfredo G. Guerreros, Amparo López‐Bernús +15 more
Harold Snieder, Liming Li, Weihua Cao, Siyan Zhan, Jun Lv +5 more
Weihua Cao, Min Wu, Zhentao Liu, Jinhua She, Luefeng Chen +2 more